Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome Sven Kracker, PhD, James Curtis, BSc, Mohammad A.A. Ibrahim, MBBCh, MSc, PhD, FRCPath, FRCP, Anna Sediva, MD, PhD, Jon Salisbury, BSc, MD, FRCPath, Vit Campr, MD, Marianne Debré, MD, J. David M. Edgar, BSc, FRCP, FRCPath, Kohsuke Imai, MD, PhD, Capucine Picard, MD, PhD, Jean-Laurent Casanova, MD, PhD, Alain Fischer, MD, PhD, Sergey Nejentsev, MD, PhD, Anne Durandy, MD, PhD Journal of Allergy and Clinical Immunology Volume 134, Issue 1, Pages 233-236.e3 (July 2014) DOI: 10.1016/j.jaci.2014.02.020 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 B-cell lymphomas. Histologic staining of patient 1: H&E (×200) (A), CD79a (B), and Ki67 (C) staining of DLBCL of the biliary tract. H&E (×200) (D), CD20 (E), and Bcl-2 (F) staining of DLBCL of the colon. Histologic staining of patient 2 showing view atypical large cells: H&E (×200) (G), CD30 (H), and CD3 (I) staining of Hodgkin lymphoma of a cervical lymph node. H&E, Hematoxylin and eosin. Journal of Allergy and Clinical Immunology 2014 134, 233-236.e3DOI: (10.1016/j.jaci.2014.02.020) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions